Background: We previously showed that the envelope (env) sequence of a human endogenous retrovirus (HERV)-W locus on chromosome Xq22.3 is transcribed in human peripheral blood mononuclear cells. The env open reading frame (ORF) of this locus is interrupted by a premature stop at codon 39, but otherwise harbors a long ORF for an N-terminally truncated 475 amino acid Env protein, starting at an in-frame ATG at codon 68. We set out to characterize the protein encoded by that ORF. Results: Transient expression of the 475 amino acid Xq22.3 HERV-W env ORF produced an N-terminally truncated HERV-W Env protein, as detected by the monoclonal anti-HERV-W Env antibodies 6A2B2 and 13H5A5. Remarkably, reversion of the stop at codon 39 in Xq22.3 HERV-W env reconstituted a full-length HERV-W Xq22.3 Env protein.
Background
Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system affecting primarily young adults. While its precise aetiology is unknown, MS is thought to be a multifactorial disorder resulting from the interaction of environmental and genetic factors [1] . A multiple sclerosis-associated retrovirus (MSRV) has previously been suggested by cDNA clones that were generated from particleassociated RNA from plasma or supernatants of cultured cells from patients with MS [2] [3] [4] . Subsequent investigations revealed MSRV-related sequences in the human genome, the human endogenous retrovirus family type W (HERV-W) [5] .
HERVs are considered remnants of ancestral germ line infections by once active retroviruses and contribute approximately 8% of the human genome (for review see [6, 7] ). Like their exogenous counterparts, HERVs typically consist of an internal region containing gag, pro, pol, and env genes, flanked by two long terminal repeats (LTR). The number and phylogenetic relationships among HERV-W sequences in the human genome have been addressed before [8, 9] . HERV-W is a multicopy endogenous retroviral family comprising approximately 650 elements. About 280 of those elements contain internal sequences [8] . Individual HERV-W loci are defective due to the acquisition of stop-codons, truncations, and deletions. In addition, many HERV-W elements actually represent processed pseudogenes resulting from retrotransposition by long interspersed element (LINE) machinery [8, 9] . De Parseval et al. identified 13 HERV-W env elements in the human genome with full-length env genes [10] . Among these, only one HERV-W env locus on chromosome 7q21.2, named ERVWE1, has retained an uninterrupted open reading frame (ORF) for a functional envelope (Env) protein, termed Syncytin-1, which is likely involved in placental morphogenesis [10, 11] .
A number of previous reports have suggested a possible role of Syncytin-1 and/or MSRV Env protein in the pathogenesis of MS [4, [12] [13] [14] [15] [16] [17] [18] [19] . MSRV/HERV-W env RNA is more abundant in autopsied brain tissue from patients with MS than from controls [12, 16, 17, 19] . A monoclonal anti-HERV-W Env antibody (mAb 6A2B2) detects an antigen expressed in actively demyelinating brain lesions from patients with MS [12, 16, 18] . Importantly, expression of Syncytin-1 in astrocytes induces release of mediators that are cytotoxic to oligodendrocytes (the cells responsible for myelination) in vitro, and the expression of Syncytin-1 in murine models causes oligodendrocyte loss and demyelination in vivo [16, 18] . On the other hand, MSRV Env protein (AAK18189.1) has been suggested to have superantigen-like properties [4] , and the surface (SU) domain of MSRV Env, which is 87% identical to Syncytin-1, was reported to have proinflammatory effects via activation of CD14 and tolllike receptor 4 [15] .
Despite the potential involvement of Syncytin-1 and MSRV Env in MS, the precise origin of MSRV env sequences and their relation to endogenous HERV-W env loci has not been clear [19] [20] [21] [22] [23] . We recently proposed that formerly reported MSRV env sequences may be explained as being derived from transcripts of various genomic HERV-W env loci or from recombinations among those transcripts [24] . By analogy to data obtained from a study of transcribed HERV-W env loci in human peripheral blood mononuclear cells (PBMC), and from a study of transcribed HERV-K(HML-2) loci, it seems possible that those recombinations occurred in vitro because of template switches of reverse transcriptase during cDNA generation and/or via PCR-mediated recombinations [24, 25] .
In particular, our analyses showed that the SU region and the 5′ part of the transmembrane (TM) region of the reported MSRV env sequence AF331500 are highly similar to a HERV-W env locus on human chromosome Xq22.3, while the 3′ part of the TM region of AF331500 is highly similar to a HERV-W element on chromosome 5p12. Another published MSRV env sequence (AF127228) was found to be almost identical with the HERV-W locus on chromosome Xq22.3 as well [24] . The Xq22.3 HERV-W env locus is quite remarkable as it harbors an almost complete ORF for a full-length HERV-W Env protein, only interrupted by a single premature stop at codon 39. The longest possible ORF of HERV-W Xq22.3 env, starting at an in-frame ATG at codon 68, could produce an N-terminally truncated HERV-W Env protein of 475 amino acids. Others and we previously showed that Xq22.3 HERV-W env is transcribed in human PBMC [24, 26, 27] . Similar to other transcribed HERV-W elements, the Xq22.3 locus lacks a 5′LTR promotor, suggesting that another upstream promotor drives its transcription [26, 27] . While that promotor remains to be identified, Xq22.3 HERV-W env transcripts indicate that the locus fulfills one essential prerequisite for protein production.
Intriguingly, it turned out that anti-HERV-W Env mAb 6A2B2 (detecting an antigen in MS brain lesions, see above) was raised against a 379 amino acid sequence encoded by MSRV env clone AF127228, which, except for two C-terminal amino acid exchanges, is identical to the Xq22.3 HERV-W Env amino acid sequence [11, 24] . Although 6A2B2 may crossreact with Syncytin-1 [11, 28, 29] , these findings open up the possibility that the protein detected by 6A2B2 in MS lesions may in fact be derived from Xq22.3 HERV-W env. Nonetheless, it was unknown whether a protein encoded by Xq22.3 HERV-W env can be expressed in human cells.
We herein show that Xq22.3 HERV-W env is capable of producing an N-terminally truncated HERV-W Env protein ex vivo. Reversion of the stop codon at position 39 in Xq22.3 HERV-W env results in the expression of a reconstituted full-length HERV-W Env protein. We characterize properties of truncated and reconstituted Xq22.3 HERV-W Env in comparison to Syncytin-1 and MSRV Env. We also confirm that mAb 6A2B2 detects an antigen expressed in placenta and MS brain lesions. Our data support the idea that not only HERVs with ORFs for complete retroviral proteins but also defective HERV elements may be capable of producing pieces of HERV proteins, which, speculatively, may exert functions in human physiology or pathology.
Results
Expression of an N-terminally truncated Env protein from HERV-W Xq22. 3 We previously found that formerly published MSRV env sequences (AF331500, AF127228) are highly similar to a HERV-W env element located on the negative strand of human chromosome Xq22.3 (nucleotides 106,182,017-106,184,757, March 2006 human genome assembly) [24] . The Xq22.3 HERV-W locus represents a HERV-W processed pseudogene [8] and consists of 3′ portions of the pol gene, the complete env gene, and U3 and R regions of the 3′LTR ( Figure 1A ). The primary sequence of the Env protein encoded by Xq22.3 HERV-W env is shown in Figure 1B .
To analyze the coding capacity of Xq22.3 HERV-W env, we PCR-amplified from human genomic DNA a 1862 bp sequence beginning at the ATG at codon 68 of Xq22.3 HERV-W env and containing the putative 475 amino acid HERV-W env ORF as well as the 3′LTR portions ( Figure 1A ). The amplicon was cloned into phCMV, a eukaryotic expression vector under the control of a strong hCMV promotor, generating phCMV-Xq22. Figure 1A ). For comparative analysis with phCMVXq22.3 Env FLΔStop we included plasmid phCMV-MSRV Env (pV14), containing the AF331500 MSRV env sequence. The structure and possible origin of the AF331500 MSRV env sequence were previously discussed in detail [24] . Finally, since Synyctin-1 currently represents the only known functional and thoroughly characterized HERV-W Env protein [29] , we also employed the phCMV-Syncytin-1 (PH74) expression vector in this investigation.
Remarkably, reversion of the stop codon in Xq22. 
Specificities of different anti-HERV-W Env antibodies for HERV-W Env constructs
In addition to mAb 13H5A5 and the anti-Syncytin-1 pAb, we also studied the specificity for HERV-W Env proteins of a pAb directed against the 80 C-terminal amino acids of Xq22.3 HERV-W Env. This pAb was generated with the aim of producing a polyclonal rabbit serum that specifically targets Xq22.3 Env. The Cterminal region of Xq22.3 Env was chosen as it displays a number of residues different from MSRV Env and Syncytin-1 ( Figure 1B) . Indeed, the anti-Xq22.3 Env pAb detected Xq22.3 Env and Xq22.3 Env FLΔStop, but only very weakly MSRV Env ( Figure 2A , second panel from bottom). However, it cross-reacted with Syncytin-1, which precluded its use as a tool for exclusive detection of Xq22.3 Env.
We also investigated specificity of mAb 6A2B2 for proteins produced by the different HERV-W Env expression vectors. In our hands, 6A2B2 did detect Xq22.3 Env, Xq22.3 Env FLΔStop, and MSRV Env, but not Syncytin-1 ( Figure 2A , second panel from top). A band of~43 kDa was additionally observed in blots developed with 6A2B2, and infrequently also in blots developed with 13H5A5. This~43 kDa band was judged unspecific as it was also detected in lysates from a cell line (B95.8) derived from a new world monkey that lacks HERV-W [30] (data not shown).
Expression of the different HERV-W Env proteins and specificity of the different HERV-W Env antibodies for the various HERV-W Env proteins were also investigated by immunocytochemistry. As shown in Figure 3 , results obtained by immunocytochemistry were consistent with the immunoblot data. Noteworthy, the protein encoded by phCMV-Xq22.3 Env FL was readily detectable by immunocytochemistry, which likely reflects the higher sensitivity of immunocytochemistry as compared to immunoblots, and further confirms that phCMVXq22.3 Env FL has coding capacity. Xq22.3 Env is unglycosylated, does not form oligomers, and is not located to the cell surface Syncytin-1 has been reported to be a moderately glycosylated protein with seven N-linked glycosylation sites [29] . By analogy, we studied the glycosylation pattern of the different HERV-W Env constructs using peptide-Nglycosidase (PNGase F) digestion. In agreement with previous findings [29] , PNGase F treatment reduced the molecular mass of Syncytin-1 by about 20 kDa ( Figure  4A ). A similar reduction was observed for Xq22.3 Env FLΔStop and MSRV Env, demonstrating that these proteins are glycosylated in a pattern similar to Syncytin-1. To analyze the capacity of the various HERV-W Env proteins to form oligomers, immunoblots were carried out under reducing and non-reducing conditions. Nonreducing conditions resulted in several high molecular weight bands for Syncytin-1, Xq22.3 Env FLΔStop, and MSRV Env, but no such oligomeric complexes could be observed for Xq22.3 Env ( Figure 4B ). While the exact composition of those higher molecular weight complexes remains to be determined, our results indicate that Syncytin-1, Xq22. (HNKR) ( Figure 1B) Figure 1B ). In addition, proper cleavage into SU and TM domains is required for fusogenicity of Syncytin-1 [29] . Absence of the fusogenic four amino acid deletion and lack of cleavage ( Figure 5 ) therefore sufficiently explain the inability of Xq22.3 HERV-W Env proteins to induce syncytia.
RNA transcripts from the Xq22.3 HERV-W env locus have the correct orientation for translation of a Xq22.3 HERV-W Env protein
The finding that Xq22.3 HERV-W Env can be expressed ex vivo opens the possibility that the protein might also be expressed in vivo. Transcription of mRNA from the Xq22.3 HERV-W env locus is an essential prerequisite for such an expression. By using RT-PCR followed by cloning and sequencing of PCR products, we have previously shown that the Xq22.3 HERV-W env locus is indeed transcribed in human PBMC [24] . However, since the reverse transcriptase step in that study involved random hexanucleotide primers it remained to be confirmed that the Xq22.3 HERV-W env locus is transcribed in a sense direction, allowing for subsequent translation of Xq22.3 HERV-W Env protein.
To clarify this point we performed strand specific reverse transcriptase reactions using primers specific for either sense or antisense transcripts from the Xq22.3 HERV-W env locus. Indeed, Xq22.3 HERV-W env mRNA is transcribed in a sense orientation with respect to the Xq22.3 HERV-W env gene; that is, it has the correct orientation for subsequent translation into a protein ( Figure 7 ). Cloning and sequencing of the respective amplicon ( Figure 7 , lane 2) confirmed that it originated from Xq22.3 HERV-W env (data not shown).
Monoclonal antibody 6A2B2 detects an antigen expressed in placenta and acute MS lesions
Previous studies have demonstrated that mAb 6A2B2, which has been raised against a 379 amino acid fragment that except for two C-terminal amino acid exchanges is identical to the Xq22.3 HERV-W Env amino acid sequence [24] , reacts with an antigen that is expressed in human placenta as well as in inflammatory brain lesions from patients with MS [11, 12, 16, 18] . Having characterized the specificity of mAb 6A2B2 extensively in the present work (Figures 2A, 3 Figure 2B and text). To confirm the specificity of observed bands, the Xq22.3 pAb was preadsorbed with either TrpE alone or TrpE fused to the C-terminal amino acid fragment of Xq22.3 Env which was used for generation of the anti-Xq22.3 Env pAb.
( Figure 8A ). Staining with mAb 6A2B2 of an actively demyelinating plaque from a patient with fulminant MS revealed strongly positive immunoreactivity in activated microglia/macrophages, mononuclear cells, and endothelial cells ( Figure 8B ). To further define the antigen detected by mAb 6A2B2 in placenta, double immunofluorescence was performed with mAb 6A2B2 and anti-Syncytin-1 pAb ( Figure 8C-F) . Similar to results from conventional immunohistochemistry, mAb 6A2B2 showed a diffuse cytoplasmic staining of the syncytiotrophoblast cell layer as well as of cells within the placental mesenchyme ( Figure 8C ). In contrast, immunoreactivity of anti-Syncytin-1 pAb was most prominent at the menbrane of the syncytiotrophoblast ( Figure 8D ). As also indicated by the overlay (Figure 8F ), these data suggest that mAb 6A2B2 and the anti-Syncytin-1 pAb recognize different antigens in placental tissue.
Discussion
We herein show that a processed HERV-W pseudogene which is located on chromosome Xq22.3 and discloses an N-terminally truncated 475 amino acid long env ORF can produce an N-terminally truncated HERV-W Env protein ex vivo. We named this protein N-Trenv (for Nterminally truncated Env). By analogy to the ERVWE1 gene encoding Syncytin-1, we propose to designate the Xq22.3 HERV-W env gene that encodes N-Trenv ERVWE2. While the ERVWE1 gene has been the only HERV-W env locus shown to be capable of producing a protein so far, our results establish Xq22.3 HERV-W env (ERVWE2) as the second HERV-W env element in the human genome that has retained coding capacity. Viral membrane glycoproteins, such as retroviral Env proteins, are normally synthesized in the endoplasmic reticulum [31] . Targeting of nascent polypeptide chains of retroviral Env proteins to the endoplasmic reticulum membrane is brought about by a short stretch of amino acids at the N-terminus of the protein, the so-called signal peptide [32] . Due to its N-terminal truncation NTrenv lacks a signal peptide and is therefore very likely synthesized on free ribosomes. Consequently, N-Trenv is not expected to undergo the usual maturation steps of full-length retroviral Env proteins. Indeed, N-Trenv is an unglycosylated protein, that does not form oligomers and is not transported to the cell surface. While functional properties of N-Trenv are currently unknown, those features suggest that in terms of function N-Trenv may behave quite differently from full-length retroviral Env proteins. Remarkably, reversion of the premature stop at codon 39 in ERVWE2 "resurrected" full-length Xq22.3 HERV-W Env protein which then became glycosylated, formed oligomers, and was expressed at the cell surface, just like the full-length HERV-W Env protein Syncytin-1 [29] . A single nucleotide difference in The Xq22.3 HERV-W env locus is transcribed in a sense orientation. The direction of RNA transcripts from the Xq22.3 HERV-W env locus was determined by reverse transcription using strand-specific first strand cDNA synthesis prior to PCR. The localization of the strand-specific primers (depicted by small arrows) relative to the Xq22.3 HERV-W env transcript is shown on top. Total RNA isolated from human PBMC was subjected (+) or not (-) to reverse transcription (RT) using either the sense or antisense primer as strand specific primer in the RT reaction. Subsequent amplification by PCR was performed employing both sense and antisense primers. The expected size of the amplified fragment is 305 bp. H 2 O, PCR negative control. Human genomic DNA (gDNA) served as positive control.
ERVWE2 can therefore dramatically alter properties of the ERVWE2 gene product. Nevertheless, unlike Syncytin-1, reconstituted Xq22.3 HERV-W Env does not appear to be cleaved into SU and TM domains, due to an amino acid mutation in the furin cleavage motif. As cleavage is prerequisite for proper Env function, it is doubtful whether reconstituted Xq22.3 HERV-W Env could represent a fully functional retroviral Env protein that confers infectivity on retrovirus particles, as it was shown for Syncytin-1 [33] .
Given the fundamental changes in the properties of N-Trenv resulting from elimination of the premature stop codon in ERVWE2, one may speculate whether a suppression of this stop codon could occur in human beings in vivo leading to re-expression of full-length Env with possible functional consequences. Furthermore, it would be interesting to know whether there exist ERVWE2 alleles in the human population that lack the stop codon. An approach to test this hypothesis would be a genetic one, with a screening for mutations in the ERVWE2 stop codon in the general population, or at a more refined level, in certain patient groups, e.g. individuals suffering from MS.
Others and we have previously shown expression of Xq22.3 HERV-W env transcripts in human PBMC [24, 26, 27] . Using strand-specific reverse transcription, we here confirm that Xq22.3 HERV-W env is transcribed in the correct orientation for subsequent translation into a protein. The overall structure of Xq22.3 HERV-W env transcripts, such as location of upstream transcription initiator(s), downstream polyadenylation signals, and potential splicing of transcripts, must be addressed in separate studies. An obviously important question is whether N-Trenv may be expressed in the human organism in vivo. As our analysis showed, mAb 13H5A5 appears to specifically detect N-Trenv, but not Syncytin-1, and could thus be suited for immunohistochemical studies addressing in vivo expression of N-Trenv. Indeed, in a previous immunohistochemical study mAb 13H5A5 was shown to detect an antigen expressed in microglia, lymphocytes, and endothelial cells in formalin-fixed, paraffin-embedded normal human brain tissue and inflammatory MS brain lesions, which were pretreated for antigen retrieval [13] . These data point towards the possibility that N-Trenv could be expressed in normal and diseased human brain in vivo. Nevertheless, providing definitive proof that the protein product of a specific HERV locus is expressed in vivo is not a simple task. For instance, it cannot be excluded that besides ERVWE2 further defective HERV-W env loci in the human genome may have the capacity to express incomplete HERV-W Env proteins that might accidentally contain the epitope recognized by mAb 13H5A5. If this was the case, it would be quite challenging to dissect from which specific HERV-W env locus the observed proteins precisely originate. Our present and previously reported findings do therefore not provide formal prove that NTrenv is expressed in vivo, underscoring the complexity of investigations on HERV protein expression in vivo.
Since mAb 6A2B2 was raised against a 379 amino acid fragment that is identical to the N-Trenv amino acid sequence except for two C-terminal amino acid exchanges [24] , detection of N-Trenv, reconstituted fulllength Xq22.3 Env, and MSRV Env by 6A2B2 was expected. However, in our hands 6A2B2 did not recognize Syncytin-1. This was an unanticipated finding as 6A2B2 has previously been reported to detect Syncytin-1 [11, 28, 29] . A possible explanation for this discrepancy could be that 6A2B2 recognizes an epitope that is conformational or only exhibited by oligomerized forms of Syncytin-1 and that was lost under the experimental conditions applied in our study. Consistent with this idea, in a previous work which reported detection of Syncytin-1 by 6A2B2 in an immunoblot, the respective experiment was carried out under non-reducing conditions [29] . Also consistent with this idea, mAb 6A2B2 was previously shown to react with transiently expressed Syncytin-1 in flow cytometry experiments, where conformational epitopes should be detectable [29] .
However, in double immunofluorescence experiments of placental tissue with mAb 6A2B2 and anti-Syncytin-1 pAb both antibodies revealed different staining patterns.
Staining with anti-Syncytin-1 pAb was most prominent at the syncytiotrophoblast membrane. Consistent with the detection of Syncytin-1 by the anti-Syncytin-1 pAb in immunoblots and immunocytochemistry, and Syncytin-1 being a membrane-associated protein, this finding is compatible with the detection of Syncytin-1 at the syncytiotrophoblast membrane by the anti-Syncytin-1 pAb. In contrast, membrane-associated immunoreactivity was not observed with mAb 6A2B2 which revealed a more diffuse cytoplasmic staining of the syncytiotrophblast cell layer as well as of cells within the placental mesenchyme. Altogether, these data suggest that, in keeping with our findings on the specificity of mAb 6A2B2 for HERV-W Env proteins in immunoblots and immuncytochemistry, mAb 6A2B2 might also recognize an antigen that is different from Syncytin-1 in immunohistochemistry. It follows that the immunoreactivity observed in MS lesions stained with mAb 6A2B2 in former studies [12, 16, 18] and this work may indicate expression of an HERV-W Env antigen different from Syncytin-1 in MS brain lesions. Similar to what has been discussed above for mAB 13H5A5, while the precise identity of the antigen recognized by mAb 6A2B2 in placental tissue and MS brain lesions remains to be clarified, N-Trenv is one possibility.
Finally, it is well established that some HERV loci in the human genome have the capacity to produce proteins that can be expressed under physiological but also pathological conditions [7, 34] . Research in this field has primarily focused on those few HERV elements that harbor intact ORFs coding for complete retroviral proteins [10] . Nevertheless, there may be instances in which short proteins also produced by highly defective HERV loci may exert a biologically significant function [35] . Our present findings further strengthen the idea that incomplete or truncated HERV loci also may be capable of producing pieces of proteins.
Conclusions
In summary, we show that a partially defective HERV-W env gene on chromosome Xq22.3, that we propose to name ERVWE2, can produce ex vivo an N-terminally truncated HERV-W Env protein, named N-Trenv, and has thus retained a coding capacity. Our own and previously published data are compatible with the possibility that N-Trenv could also be expressed in vivo, although formal proof is still required. While most of the numerous HERV elements in the human genome are defective and have therefore been considered functionless, our present findings suggest that defective HERV elements in the human genome may be capable of also producing partial HERV proteins. It is tempting to speculate that those HERV protein fragments could play a role in human physiology or pathology. [11] , and phCMV-MSRV Env (clone pV14, AF 331500) [4] were kindly provided by Hervé Perron (Geneuro, Switzerland). As an additional control, we also inserted the MSRV env sequence in antisense orientation into phCMV.
Methods

Plasmids
Antibodies
Polyclonal anti-Syncytin-1 rabbit antisera (anti-Syncytin-1 pAb K342 and K343) were generated as previously described [36, 37] by immunization of rabbits with a fusion protein consisting of an approximately 6 kDa fragment of the N-terminus of Syncytin-1 and E. coli anthranilate synthetase (TrpE). A polyclonal anti-Xq22.3 HERV-W Env antiserum (anti-Xq22.3 Env pAb) was produced similarly by immunizing rabbits with a fusion protein consisting of the 80 C-terminal amino acids (463-542) of Xq22.3 HERV-W Env fused to TrpE (see also Figure 1A ). In competition experiments, the anti-Xq22.3 HERV-W Env antiserum was preadsorbed overnight with either bacterially expressed TrpE-Xq22.3 HERV-W Env fusion protein or TrpE alone. The mouse mAb 13H5A5 (IgG1), directed against an epitope in the SU domain of MSRV Env [15] , and peroxidase labeled mouse mAb 6A2B2 (IgG1) were a kind gift from Hervé Perron. As previously discussed in detail, mAb 6A2B2 was raised against a 379 amino acid sequence encoded by MSRV env clone AF127228, which is identical to the Xq22.3 HERV-W Env amino acid sequence but for two Cterminal amino acid exchanges [11, 24] .
Transient expression and characterization of HERV-W Env proteins
HeLa human cervical carcinoma cells were cultured in Dulbecco′s modified Eagle's medium containing 10% FCS (PAA), penicillin (100 U/ml), and streptomycin (100 μg/ml). Cells were maintained at 37°C in a 5% CO 2 atmosphere. Cells were free of mycoplasma con- 
Formation of syncytia
HeLa cells were plated at 5 × 10 5 cells/per well in 6-well plates and transfected (Lipofectamine 2000) with different HERV-W Env constructs. After 24 hours cells were stained with May-Grünwald and Giemsa solutions to visualize syncytia formation and inspected with a Leitz Aristoplan microscope.
Immunohistochemistry
Immunohistochemistry was carried out as previously described [38] on formalin-fixed paraffin-embedded post-mortem brain tissue sections from a 76-year old woman with fulminant MS (Marburg′s variant) as well as on formalin-fixed paraffin-embedded tissue sections from normal human placenta. For double immunofluorescence Cy2-conjugated anti-mouse-IgG and Cy3-conjugated anti-rabbit IgG (Dianova, Hamburg, Germany) were used as secondary antibodies.
Strand specific RT-PCR
Total RNA was prepared from PBMC using the RNeasy Mini kit (Qiagen) and eluted into 60 μl of RNase-free H 2 O dd . RNA concentration and purity was assessed spectrophotometrically. Contaminating DNA was removed using the TURBO DNA-free Kit (Ambion Inc.) following the protocol for rigorous DNAse treatment as described before [24] . Reverse transcription was carried out using the Xq22.3 HERV-W env strand-specific primers Sense 5′-GCTGCTGTACAACCAGTAGCTC-3′ and Antisense 5′-TTCTCTTGCCTGACCTTGAAT-3′ and SuperScript III reagents (Invitrogen) at 55°C for increased specificity. Negative controls were generated in parallel for each sample by omitting reverse transcriptase from the reaction. PCR was carried out as reported [24] using above mentioned primers. For further verification PCR products were cloned and sequenced as described before [24] .
